Literature DB >> 21686923

Malignant neurilemoma with xeroderma pigmentosum.

Li Na Wang1, Min Jian Ma, Ji Tong Shi.   

Abstract

UNLABELLED: Xeroderma pigmentosum is a rare autosomal recessive disease characterised by hypersensitivity to sunlight, and is associated with a high incidence of skin cancer. We report a case of xeroderma pigmentosum with malignant neurilemoma in a 46-year-old woman which is unique due to its presentation, which was confirmed histopathologically. TRIAL REGISTRATION NUMBER: 31095.

Entities:  

Year:  2009        PMID: 21686923      PMCID: PMC3028145          DOI: 10.1136/bcr.06.2008.0127

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  5 in total

1.  [Ophtalmologic manifestations of the xeroderma pigmentosum].

Authors:  Madiha Mseddi; Dorra Sellami; Y Elloumi; Yacine Aloulou; Bourane Kammoun; Hamida Turki; Jamel Feki; Abdelmajid Zahaf
Journal:  Tunis Med       Date:  2006-09

Review 2.  Xeroderma pigmentosum.

Authors:  Johannes Norgauer; Marco Idzko; Elisabeth Panther; Oliver Hellstern; Yared Herouy
Journal:  Eur J Dermatol       Date:  2003 Jan-Feb       Impact factor: 3.328

3.  Malignant schwannoma associated with xeroderma pigmentosum in a patient belonging to complementation group D.

Authors:  T Nakamura; T Ono; K Yoshimura; T Arao; S Kondo; M Ichihashi; A Matsumoto; Y Fujiwara
Journal:  J Am Acad Dermatol       Date:  1991-08       Impact factor: 11.527

4.  Survey of 1264 patients with orbital tumors and simulating lesions: The 2002 Montgomery Lecture, part 1.

Authors:  Jerry A Shields; Carol L Shields; Richard Scartozzi
Journal:  Ophthalmology       Date:  2004-05       Impact factor: 12.079

Review 5.  Malignant trigeminal schwannoma associated with xeroderma pigmentosum--case report.

Authors:  S Yamashiro; S Nagahiro; C Mimata; J Kuratsu; Y Ushio
Journal:  Neurol Med Chir (Tokyo)       Date:  1994-12       Impact factor: 1.742

  5 in total
  1 in total

Review 1.  Xeroderma pigmentosum: an updated review.

Authors:  Alexander Kc Leung; Benjamin Barankin; Joseph M Lam; Kin Fon Leong; Kam Lun Hon
Journal:  Drugs Context       Date:  2022-04-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.